Key Events This Week
10 Aug: Golden Cross formation signalling potential bullish breakout
11 Aug: Upgrade to Hold rating on improved technicals and fair valuation
11 Aug: Technical momentum shift amid mixed indicator signals
14 Aug: Week closes at Rs.5,405.25 (+2.93%) outperforming Sensex

Dr Agarwals Eye Hospital Ltd Upgraded to Hold on Improved Technicals and Fair Valuation
2026-08-11 08:36:40Dr Agarwals Eye Hospital Ltd has seen its investment rating upgraded from Sell to Hold, reflecting notable improvements across technical indicators and valuation metrics. The company’s financial trends remain robust, supported by consistent quarterly performance and healthy long-term growth, while technical signals have shifted to a more positive stance, prompting a reassessment of its market position.
Read full news article
Dr Agarwals Eye Hospital Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals
2026-08-11 08:05:18Dr Agarwals Eye Hospital Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a blend of bullish and bearish signals across key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment for the hospital sector stock.
Read full news article
Golden Cross Forms in Dr Agarwals Eye Hospital Ltd — Mixed Technical Signals Cloud the Outlook
2026-08-10 18:00:41The 50-day moving average has crossed above the 200-day moving average for Dr Agarwals Eye Hospital Ltd, signalling a golden cross on 10 Aug 2026. Yet, the broader technical picture is conflicted, with monthly momentum indicators showing mild bearishness despite weekly signals leaning bullish. This divergence raises questions about the reliability of the crossover as a standalone indicator.
Read full news articleDr Agarwals Eye Hospital Gains 5.13%: Valuation and Technical Shifts Drive Weekly Momentum
2026-08-08 16:03:30
Key Events This Week
3 Aug: Stock opens at Rs.5,009.70, up 0.29% amid cautious technical outlook
4 Aug: Q1 FY27 results reveal strong revenue growth but margin pressure; technical momentum shifts mildly bearish
5 Aug: Valuation metrics improve, signalling renewed price attractiveness despite Mojo Grade downgrade
7 Aug: Week closes at Rs.5,251.45, up 5.13% for the week, outperforming Sensex

Dr Agarwals Eye Hospital Ltd: Valuation Shifts Signal Renewed Price Attractiveness
2026-08-05 08:02:11Dr Agarwals Eye Hospital Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive valuation grade. This change is underpinned by a recalibration of key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the hospital chain favourably against its peers in the hospital sector. Despite a recent downgrade in its overall Mojo Grade to Sell, the valuation appeal of the stock has improved, offering investors a nuanced perspective on its price attractiveness amid broader market dynamics.
Read full news articleAre Dr Agarwals Eye Hospital Ltd latest results good or bad?
2026-08-04 19:20:08Dr Agarwal's Eye Hospital Ltd has reported its financial results for Q1 FY27, showcasing a robust revenue performance with net sales reaching ₹142.97 crores, reflecting a year-on-year growth of 22.28%. This marks the eighth consecutive quarter of revenue growth, indicating a consistent upward trajectory driven by strong patient footfall and successful capacity expansion initiatives. The standalone net profit for the quarter was ₹23.38 crores, which represents a year-on-year increase of 35.46%. However, the operating margin has contracted by 148 basis points year-on-year to 30.26%, despite a sequential improvement from the previous quarter. This contraction suggests that while revenue is growing, the company is facing rising costs, particularly in employee expenses, which increased significantly year-on-year. The net profit margin also improved to 16.35% from 14.76% in the same quarter last year, primarily...
Read full news article
Dr Agarwal's Eye Hospital Q1 FY27: Strong Revenue Growth Masks Margin Pressure and Technical Weakness
2026-08-04 09:48:30Dr Agarwal's Eye Hospital Ltd., a leading chain of eye hospitals with predominant presence in Tamil Nadu, reported robust topline expansion in Q1 FY27 with net sales surging 22.28% year-on-year to ₹142.97 crores. Net profit stood at ₹23.38 crores, marking a 35.49% increase from ₹17.26 crores in Q1 FY26, whilst sequential growth of 43.97% from Q4 FY26's ₹16.24 crores demonstrated strong operational momentum. The stock, currently trading at ₹5,109.05 with a market capitalisation of ₹2,503 crores, has gained 1.98% in post-result trading, though technical indicators signal underlying weakness with a mildly bearish trend.
Read full news article
Dr Agarwals Eye Hospital Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-04 08:06:31Dr Agarwals Eye Hospital Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish stance, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 0.29%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes and their implications for the hospital sector small-cap stock.
Read full news articleBoard Meeting Outcome for Outcome Of The Board Meeting Held On August 03 2026
03-Aug-2026 | Source : BSEOutcome of the proceedings of the Board Meeting held on August 03 2026 is submitted.
Results- Unaudited Financial Results For The Quarter Ended June 30 2026
03-Aug-2026 | Source : BSEUnaudited Financial Results for the quarter ended June 30 2026 is submitted.
Announcement under Regulation 30 (LODR)-Change in Management
03-Aug-2026 | Source : BSEReappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27 is submitted.
Corporate Actions
No Upcoming Board Meetings
Dr Agarwals Eye Hospital Ltd has declared 30% dividend, ex-date: 07 Nov 25
No Splits history available
No Bonus history available
No Rights history available






